video corpo
Add to favorites

#Industry News

First clinical study patient has novel drug delivery system implanted for Parkinson’s trial

Joint clinical study between Renishaw and Herantis Pharma for Parkinsons

On November 8th, 2017 the first patient in a new clinical study was implanted with a novel drug delivery system, developed by Renishaw, The procedure took place at Karolinska University Hospital in Stockholm, Sweden. The implantation marks the beginning of a joint clinical study between Renishaw and Herantis Pharma. This phase I - II clinical study will investigate the treatment of Parkinson's disease using Cerebral Dopamine Neurotrophic Factor (CDNF) delivered with Renishaw's system.

Details

  • New Mills, Kingswood, Wotton-under-Edge GL12 8JR, UK
  • Renishaw plc

    Keywords

    Products associated